Article
- The EMBO Journal (2005) 24, 1739 - 1749
- doi:10.1038/sj.emboj.7600656
Published online: 21 April 2005
Subject Categories:
Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3
Noriko Yoneda-Kato1, Kiichiro Tomoda1, Mari Umehara1, Yukinobu Arata1 and Jun-ya Kato1
- Department of Animal Molecular Genetics, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Takayama, Ikoma, Nara, Japan
Correspondence to:
Noriko Yoneda-Kato, Graduate School of Biological Sciences, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0101, Japan. Tel.: +81 743 72 5514; Fax: +81 743 72 5519; E-mail: noriko-k@bs.naist.jp
Received 24 November 2004; Accepted 31 March 2005
Abstract
Myeloid leukemia factor 1 (MLF1) was first identified as the leukemic fusion protein NPM-MLF1 generated by the t(3;5)(q25.1;q34) chromosomal translocation. Although MLF1 expresses normally in a variety of tissues including hematopoietic stem cells and the overexpression of MLF1 correlates with malignant transformation in human cancer, little is known about how MLF1 is involved in the regulation of cell growth. Here we show that MLF1 is a negative regulator of cell cycle progression functioning upstream of the tumor suppressor p53. MLF1 induces p53-dependent cell cycle arrest in murine embryonic fibroblasts. This action requires a novel binding partner, subunit 3 of the COP9 signalosome (CSN3). A reduction in the level of CSN3 protein with small interfering RNA abrogated MLF1-induced G1 arrest and impaired the activation of p53 by genotoxic stress. Furthermore, ectopic MLF1 expression and CSN3 knockdown inversely affect the endogenous level of COP1, a ubiquitin ligase for p53. Exogenous expression of COP1 overcomes MLF1-induced growth arrest. These results indicate that MLF1 is a critical regulator of p53 and suggest its involvement in leukemogenesis through a novel CSN3–COP1 pathway.
Keywords:
- COP1,
- CSN3,
- MLF1,
- oncogenesis,
- p53
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Drug discovery in the ubiquitin?proteasome system
Nature Reviews Drug Discovery Review (01 Jul 2006)
Revisiting the COP9 signalosome as a transcriptional regulator
EMBO reports Review (01 Apr 2009)
Revisiting the COP9 signalosome as a transcriptional regulator
EMBO reports Review (01 Apr 2009)
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
Oncogene Original Article
Molecular Systems Biology Article (08 May 2007)



